Guardant Health (GH) revenue

Revenue · fiscal 2025
$982.02M

Guardant Health (GH) reported revenue of $982.02M in fiscal 2025 (the year ended December 31, 2025). That is 32.9% higher than the $739.02M of fiscal 2024. Figures as of 18 Nov 2026, 10:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$982.02M
Change on fiscal 2024
+32.9%
Growth, 5 years
+27.9% a year
Highest on record
$982.02Mfiscal 2025
Lowest on record
$25.25Mfiscal 2016
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Guardant Health revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 27.9% a year. Across the 10 fiscal years on record (2016–2025), the highest was $982.02M in fiscal 2025 and the lowest $25.25M in fiscal 2016.

History · 10 fiscal years

Revenue by fiscal year

Guardant Health revenue, year by year

Guardant Health (GH) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$982.02M 32.9% up
2024$739.02M 31.0% up
2023$563.95M 25.5% up
2022$449.54M 20.3% up
2021$373.65M 30.3% up
2020$286.73M 33.8% up
2019$214.38M 136.5% up
2018$90.64M 81.9% up
2017$49.84M 97.4% up
2016$25.25M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Guardant Health and comparable companies
CompanyRevenueFiscal year
Viatris VTRS$14.30B2025
Tenet Healthcare THC$21.31B2025
BioNTech BNTX€2.87B2025
Guardant Health GH$982.02M2025
Alnylam Pharmaceuticals ALNY$3.71B2025
Zimmer Biomet Holdings ZBH$8.23B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GH

Guardant Health, figure by figure

Guardant Health (GH) overview: price, valuation and scorecardAll health care companies by market value

Guardant Health revenue: questions and answers

What is Guardant Health's revenue?

Guardant Health (GH) reported revenue of $982.02M in fiscal 2025 (the year ended December 31, 2025). That is 32.9% higher than the $739.02M of fiscal 2024.

What is the growth rate of Guardant Health's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 27.9% a year.

What are the highest and lowest revenue figures on record for Guardant Health?

Across the 10 fiscal years on record (2016–2025), the highest was $982.02M in fiscal 2025 and the lowest $25.25M in fiscal 2016.

How is Guardant Health's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Guardant Health it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Guardant Health (GH) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/GH/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.